Jiangsu GDK Biotechnology Co Ltd Cash Flow-to-Debt Ratio
Jiangsu GDK Biotechnology Co Ltd cash flow-to-debt ratio. Jiangsu GDK Biotechnology Co Ltd (688670) has a Cash Flow-to-Debt Ratio of -0.17x as of September 2025, meaning its operating cash flow of CN¥-44.96 Million could theoretically repay 0% of its total liabilities (CN¥257.05 Million) in one year. Check 688670 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Jiangsu GDK Biotechnology Co Ltd (2017–2025)
Cash flow-to-debt ratio of Jiangsu GDK Biotechnology Co Ltd from 2017 to 2025. Historical debt coverage capacity for Jiangsu GDK Biotechnology Co Ltd across 9 annual periods. Check how high is Jiangsu GDK Biotechnology Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Jiangsu GDK Biotechnology Co Ltd Cash Flow-to-Debt Ratio by Year (2017–2025)
Jiangsu GDK Biotechnology Co Ltd cash flow-to-debt ratio by year from 2017 to 2025. Year-by-year debt coverage analysis for Jiangsu GDK Biotechnology Co Ltd. For the full cash flow conversion analysis, see Jiangsu GDK Biotechnology Co Ltd cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.52x | CN¥-166.45 Million | CN¥319.50 Million | ▼ -1.2% |
| 2024 | -0.51x | CN¥-131.39 Million | CN¥255.33 Million | ▼ -265.7% |
| 2023 | 0.31x | CN¥80.90 Million | CN¥260.52 Million | ▲ +195.4% |
| 2022 | 0.11x | CN¥38.60 Million | CN¥367.11 Million | ▼ -70.3% |
| 2021 | 0.35x | CN¥103.93 Million | CN¥293.12 Million | ▲ +73.5% |
| 2020 | 0.20x | CN¥109.46 Million | CN¥535.47 Million | ▲ +291.2% |
| 2019 | -0.11x | CN¥-54.05 Million | CN¥505.68 Million | ▼ -20.7% |
| 2018 | -0.09x | CN¥-35.48 Million | CN¥400.73 Million | ▲ +4.3% |
| 2017 | -0.09x | CN¥-33.24 Million | CN¥359.39 Million | — |